Moyamoya Disease: Diagnostic Work-up and First-Line Treatment
For pediatric Moyamoya disease, surgical revascularization performed at high-volume centers is the definitive first-line treatment, as it reduces stroke risk from 67% preoperatively to 4.3% at 5-year follow-up, representing a durable and marked reduction in ischemic injury. 1
Diagnostic Work-up
Initial Imaging
- MRI with MRA is the primary screening modality 1
- Look for diminished flow voids in the ICA, MCA, and ACA
- Prominent collateral flow voids in basal ganglia and thalamus are virtually diagnostic
- Diffusion-weighted imaging detects acute infarcts
- FLAIR sequences may show linear high signal in sulcal patterns (slow cortical flow)
Confirmatory Imaging
- Catheter angiography remains the gold standard for diagnosis 1
- Must include all 6 vessels: bilateral ICAs, VAs, and ECAs
- Confirms Suzuki staging
- Reveals collateral vessel patterns critical for surgical planning
- Complication risk in children with Moyamoya is no higher than in other cerebrovascular disease populations
- MRA/CTA may suffice when catheter angiography is not feasible, though they miss smaller vessel occlusions 1
Perfusion Studies (Adjunctive)
- SPECT with acetazolamide challenge, PET, or Xenon-enhanced CT can be useful 1
- Detect inadequate resting perfusion and poor blood flow reserve
- Help determine which patients need surgery
- Assess improvement after revascularization
- Increasingly important role in evaluation and treatment decisions 2
First-Line Treatment
Surgical Revascularization Indications
Surgery should be offered to children with: 1
- Ongoing ischemic symptoms, OR
- Evidence of compromised blood flow/cerebral perfusion reserve on functional studies
- Even asymptomatic children with radiographic evidence of impaired cerebral perfusion should be considered surgical candidates (Class I recommendation) 1
Surgical Approach Selection
- Indirect revascularization techniques are used in ~75% of pediatric cases 1
- Pial synangiosis is the most commonly used indirect technique
- Direct bypass (STA-MCA) or combined approaches comprise the remaining 25%
- The specific technique matters less than surgeon/institutional experience with Moyamoya 1
- All approaches yield excellent results when performed at high-volume centers 1
Critical Perioperative Management
Fluid management is paramount: 1
- Primary focus on avoiding dehydration rather than supplementation
- Careful monitoring during illness (diarrhea, vomiting)
- Attention to fluid status during exercise or hot weather
- Particular vigilance in the perioperative period
Timing Considerations
- Minimize time between diagnosis and revascularization 1
- Reasonable delays allowed for:
- Scheduling experienced anesthetic and ICU staff
- Recent infarction, infection, or hemorrhage (medical contraindications)
- No firm recommendations on specific timing, but earlier is generally better
Long-term Follow-up
Surveillance Protocol
- Annual follow-up for 3-5 years post-surgery by clinicians familiar with Moyamoya 1
- Patients with unilateral disease require annual MRA or CTA for 3-5 years to assess progression 1
Medical Management (Supportive Only)
While the guidelines focus heavily on surgical intervention, medical management is limited to:
- Hydration maintenance to prevent thrombosis
- Avoiding hypotension and blood flow fluctuations
- No established medical therapy halts disease progression 3, 4
- Antiplatelet therapy may be considered but is not a substitute for surgery 4
Key Pitfalls to Avoid
- Relying solely on MRA for diagnosis - it misses smaller vessel occlusions and collateral details needed for surgical planning 1
- Delaying surgery in asymptomatic patients with perfusion deficits - they still benefit from revascularization 1
- Inadequate perioperative fluid management - dehydration significantly increases stroke risk 1
- Failing to monitor unilateral disease - progression to bilateral involvement occurs in over one-quarter of cases 2
- Choosing low-volume centers - institutional experience is the key factor in successful outcomes, not the specific surgical technique 1
The evidence strongly supports that surgical revascularization at experienced centers provides durable stroke prevention, with meta-analysis of >1100 patients demonstrating 87% derive symptomatic benefit 2. The natural history without surgery is poor, with 67% experiencing strokes, making surgery the clear first-line treatment for appropriate candidates 1.